Significance and molecular mechanisms of natriuretic peptide family in the protection from renal dysfunction
利尿钠肽家族预防肾功能障碍的意义及分子机制
基本信息
- 批准号:11671066
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) Pathohysioloical significance of natriuretic peptide family in the animal models of renal diseasesWe have established animal models of renal diseases (anti-glomerular basement membrane antibody glomerulonephritis ; anti-GBM antibody GN, STZ diabetic nephropathy model and unilateral ureteral obstruction hydronephrosis model) in rats and mice, and elucidated the localization of natriuretic peptide family by Nothern blot analysis and immunohistochemical method using anti-ANP, BNP, CNP monoclonal antibodies. The results indicated that these peptides may be the parameter of renal dysfunction.(2) Study on the cross-talk of natriuretic peptide system and renin-angiotensin systemNatriuretic peptide system is thought to antagonize renin-angiotensin system. To clarify the intra-cellular mechanism of natriuretic psptides, we have investigated the induction of TGF-β, CTGF and extra-cellular matrix using cultured mesangial cells. We have also succeeded the cloning of rat CTGF and raised the specific antibody.(3) Kidney protection in BNP transgenic mouse and its molecular mechanismWe have established the 5/6 nephrecomized model using BNP transgenic mice which show the activation of renal renin-angiotensin system. Using this animal model, significant increase in size of glomeruli is observed in the control rats, whereas in the BNP transgenic mice, such glomerular change is not observed, showing that excessive BNP may work as kidney protection. Using this BNP transgenic mice, we have further established the unilateral ureteral obstruction hydronephrosis model and anti-GBM antibody GN model. With these models, we have shown the kidey-protection of BNP, at least in part, by the immunological mechanism.
(1)利钠肽家族在肾脏疾病动物模型中的病理生理意义我们建立了肾脏疾病动物模型(抗肾小球基底膜抗体肾小球肾炎;大鼠和小鼠抗gbm抗体GN、STZ糖尿病肾病模型和单侧输尿管梗阻肾积水模型),并利用抗anp、BNP、CNP单克隆抗体,通过northern blot分析和免疫组化方法阐明利钠肽家族的定位。结果表明,这些肽可能是肾功能不全的参数。(2)利钠肽系统与肾素-血管紧张素系统相互作用的研究利钠肽系统被认为具有拮抗肾素-血管紧张素系统的作用。为了阐明利钠肽的细胞内机制,我们利用培养的系膜细胞研究了TGF-β、CTGF和细胞外基质的诱导作用。我们还成功克隆了大鼠CTGF,并提出了特异性抗体。(3) BNP转基因小鼠的肾脏保护作用及其分子机制我们建立了5/6肾化模型,显示了肾肾素-血管紧张素系统的激活。在该动物模型中,对照大鼠肾小球明显增大,而在BNP转基因小鼠中,肾小球未见明显变化,说明过量的BNP可能具有肾保护作用。利用该BNP转基因小鼠,我们进一步建立了单侧输尿管梗阻肾积水模型和抗gbm抗体GN模型。通过这些模型,我们至少在一定程度上通过免疫机制证明了BNP的保护作用。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masato Kotani: "Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressend in human uterus."Journal of Clinical Endocrinology and Metabolism. 85(11). 4315-4322 (2001)
Masato Kotani:“通过两种前列腺素 E 受体 EP3 亚型异构体在人类子宫中表达的多种信号转导途径。”临床内分泌与代谢杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yahata K et al.: "Molecular cloning and expression of a novel klotho-related protein."J.Mol.Med.. 78(7). 389-94 (2000)
Yahata K 等人:“新型 klotho 相关蛋白的分子克隆和表达。”J.Mol.Med. 78(7)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakagawa M et al.: "Monoclonal antibody against brain natriuretic peptide and characterization of brain natriuretic peptide transgenic mice."J Hypertens.. 19. 475-483 (2001)
Nakakawa M 等人:“抗脑钠尿肽的单克隆抗体和脑钠尿肽转基因小鼠的特征。”J Hypertens.. 19. 475-483 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Atsuo Tanaka: "Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome : Could different components of aristolochic acids cause a different type of Chinese herb nephropathy?"Clinical Nephrology. 53(4). 301-306 (2000)
Atsuo Tanaka:“日本的中草药肾病表现为成人发病的范可尼综合征:马兜铃酸的不同成分会导致不同类型的中草药肾病吗?”《临床肾脏病学》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masayo Nakagawa: "Monoclonal antibody against brain natriuretic peptide (BNP) and characterization of BNP-transgenic mice."Journal of Hypertension. 19. 475-483 (2001)
Masayo Nakakawa:“抗脑钠尿肽 (BNP) 的单克隆抗体和 BNP 转基因小鼠的特征。”高血压杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGAWARA Akira其他文献
SUGAWARA Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGAWARA Akira', 18)}}的其他基金
Innovation of a novel anti-hypertensive therapy due to the inhibitionof aldosterone synthase (CYP11B2) gene expression
抑制醛固酮合酶(CYP11B2)基因表达的新型抗高血压疗法的创新
- 批准号:
22591006 - 财政年份:2010
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EFFECTS OF ALL-TRANS RETINOIC ACID AND RETINOIDS ON ANGIOGENESIS
全反式视黄酸和类视黄醇对血管生成的影响
- 批准号:
18591015 - 财政年份:2006
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of co-activator proteins on peroxisome proliferator-activated receptor (PPAR-γ-mediated gene transcription in vascular smooth muscle cells
共激活蛋白对血管平滑肌细胞过氧化物酶体增殖物激活受体(PPAR-γ介导的基因转录)的影响
- 批准号:
14571058 - 财政年份:2002
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Phosphorylation of Human Thyroid Hormone Receptor beta-1 by Casein Kinase II
酪蛋白激酶 II 磷酸化人甲状腺激素受体 beta-1
- 批准号:
09671018 - 财政年份:1997
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Joint study for the thyroid hormone receptor phosphorylation
甲状腺激素受体磷酸化联合研究
- 批准号:
08044231 - 财政年份:1996
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Defining a new mechanism of blood pressure regulation and its role during sepsis
定义血压调节的新机制及其在脓毒症期间的作用
- 批准号:
MR/Y011805/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Cuffless models to infer blood pressure from bioimpedance
无袖带模型可根据生物阻抗推断血压
- 批准号:
2319920 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Standard Grant
Blood pressure trajectory of inpatient rehabilitation stroke patients from the Determining Optimal Post-Stroke Exercise (DOSE) trial over the first 12-months post-stroke
通过确定最佳中风后运动 (DOSE) 试验得出的中风住院康复患者在中风后 12 个月内的血压轨迹
- 批准号:
493123 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents
AirPressureNYC:减少空气污染以降低纽约市公共住房居民的血压
- 批准号:
10638946 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
The mechanism of non-dipper blood pressure induced by intermittent hypoxia during sleep
睡眠间歇性缺氧引起非杓型血压的机制
- 批准号:
23K06336 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine Learning Enabled Non-contact Sensing Platform for Blood Pressure and Glucose Prediction
用于血压和血糖预测的机器学习非接触式传感平台
- 批准号:
23K11341 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
I-Corps: Blood Pressure Monitoring by a Miniaturized Cuffless Sensor
I-Corps:通过小型无袖带传感器进行血压监测
- 批准号:
2332674 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Standard Grant
Blood pressure imaging by contrast enhanced active Doppler ultrasound
通过对比增强主动多普勒超声进行血压成像
- 批准号:
23K18557 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:














{{item.name}}会员




